Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
2024 · Molecular Cancer · 87 citations
https://doi.org/10.1186/s12943-024-02108-6
X
Xin Yuan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
400
Citations
10
h-index
10
i10-index
Xin Yuan is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research & IoT and Edge/Fog Computing. The author has an h-index of 10, co-authored 69 publications.
ORCID: 0000-0002-1298-4399Papers by this author
worksMesh-reinforced reconstruction after abdominal wall desmoid tumor resection: a retrospective analysis of 16 cases
2025 · Hernia · 2 citations
https://doi.org/10.1007/s10029-025-03307-w
Exploring the predictive values of CRP and lymphocytes in coronary artery disease based on a machine learning and Mendelian randomization
2024 · Frontiers in Cardiovascular Medicine · 1 citations
https://doi.org/10.3389/fcvm.2024.1442275
The MoE-Empowered Edge LLMS Deployment: Architecture, Challenges, and Opportunities
2025 · IEEE Communications Magazine · 1 citations
https://doi.org/10.1109/mcom.001.2400717
519P Cetuximab plus capecitabine versus cetuximab as maintenance treatment in Chinese patients with RAS/BRAF wild type metastatic colorectal cancer (mCRC): A phase III, multicenter, open-label, randomized study (C-CLASSIC study)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.588
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat